About Gamma Vaccines
Gamma Vaccines is a company based in Canberra (Australia) founded in 2009.. Gamma Vaccines has raised $551.69 thousand across 1 funding round from investors including SOHO Global Health. Gamma Vaccines offers products and services including Broad Spectrum Vaccines and NDV Vaccine. Gamma Vaccines operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, Serum Institute of India, Vaxcyte and Generate Biomedicines, among others.
- Headquarter Canberra, Australia
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Gamma Vaccines Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$551.69 K (USD)
in 1 rounds
-
Latest Funding Round
$551.69 K (USD), Seed
Dec 02, 2009
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Gamma Vaccines
Gamma Vaccines offers a comprehensive portfolio of products and services, including Broad Spectrum Vaccines and NDV Vaccine. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Vaccines targeting various human and animal viruses for disease prevention.
Vaccine for Newcastle disease virus in animals and poultry.
Funding Insights of Gamma Vaccines
Gamma Vaccines has successfully raised a total of $551.69K through 1 strategic funding round. The most recent funding activity was a Seed round of $551.69 thousand completed in December 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $551,694
-
First Round
First Round
(02 Dec 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2009 | Amount | Seed - Gamma Vaccines | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Gamma Vaccines
Gamma Vaccines has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include SOHO Global Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
SOHO Global Health is engaged in herbal-based medicine development.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Gamma Vaccines
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Gamma Vaccines
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gamma Vaccines Comparisons
Competitors of Gamma Vaccines
Gamma Vaccines operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, Serum Institute of India, Vaxcyte and Generate Biomedicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| domain | founded_year | HQ Location |
Vaccines and immuno-biological drugs for infectious diseases are manufactured.
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| domain | founded_year | HQ Location |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Gamma Vaccines
When was Gamma Vaccines founded?
Gamma Vaccines was founded in 2009.
Where is Gamma Vaccines located?
Gamma Vaccines is headquartered in Canberra, Australia. It is registered at Canberra, Australian Capital Territory, Australia.
Is Gamma Vaccines a funded company?
Gamma Vaccines is a funded company, having raised a total of $551.69K across 1 funding round to date. The company's 1st funding round was a Seed of $551.69K, raised on Dec 02, 2009.
What does Gamma Vaccines do?
Gamma Vaccines was founded in 2009 in Canberra, Australia, within the biotechnology sector. Focus is placed on developing broad-spectrum, intranasal vaccines targeting human and avian influenza viruses. Inactivated virus strains are prepared using gamma irradiation to maintain protein structures, enabling intranasal administration. Potential exists for stockpiling as a universal flu vaccine for pandemic response. Additional research is conducted on vaccines for avian influenza in poultry and bacterial pneumonia prevention.
Who are the top competitors of Gamma Vaccines?
Gamma Vaccines's top competitors include Moderna, Adaptive Biotechnologies and Vaxcyte.
What products or services does Gamma Vaccines offer?
Gamma Vaccines offers Broad Spectrum Vaccines and NDV Vaccine.
Who are Gamma Vaccines's investors?
Gamma Vaccines has 1 investor. Key investors include SOHO Global Health.